USPTO serial 87918887
CLEANZINC
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CORWIN, KEVIN SCOTT
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CLEANZINC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Bloomfield Hills, MI
Bloomfield Hills, MI
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Hope V. Shovein
Hope V. Shovein Brooks Kushman P.C.1000 Town Center, 22nd FloorSouthfield, MI 48075UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antiseptic preparations; Antiseptics; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of wounds, ulcers, surgical wounds, and abscesses; Chemical reagents for medical or veterinary purposes; Irrigating solutions for eye use; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of abscesses, ulcers, wounds, burns, other infectious processes, skin injuries; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Wound dressings; Antibacterial pharmaceuticals; Cleansing solutions for medical use; Dermatological pharmaceutical products; Disposable wipes impregnated with disinfecting chemicals or compounds therefor for use in hospitals; Dressings for wounds; Dressings for surgery; Dressings for ulcers; Dressings for abscesses; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with pharmaceutical preparations in the nature of activated zinc solution for the treatment of wounds, ulcers, surgical incisions, infections and abscesses; Intravenous bags sold filled with activated zinc solution pharmaceutical preparations in the nature of activated zinc solution for the treatment of infections wounds, ulcers, surgical incisions, infections and abscesses; Medical and surgical dressings; Medical cleansers for skin and wounds; Pharmaceutical preparations for wounds; Pharmaceutical preparations for ocular or intraocular surgery; Sponges impregnated with antiseptics; Sponges impregnated with disinfecting chemicals or compounds therefor for use in hospitals and clinics for the treatment of wounds, ulcers, surgical incisions, infections and abscesses; Syringes sold filled with pharmaceutical preparations in the nature of activated zinc solution for the treatment of wounds, ulcers, surgical incisions, infections and abscesses; Therapeutic pharmaceutical for the treatment of ulcers, wounds, abscesses, other infectious processes; all of the aforementioned goods containing zinc | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 21, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 20, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 2, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 1, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jan 31, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 21, 2021 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Dec 21, 2021 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Dec 21, 2021 | PETG | PETITION TO REVIVE-GRANTED | — |
| Dec 21, 2021 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Dec 20, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 20, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 15, 2021 | EXT5 | SOU EXTENSION 5 FILED | — |
| May 18, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 14, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 14, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 14, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 10, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 6, 2020 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 6, 2020 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 6, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 16, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 14, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 14, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 14, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 14, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 12, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 12, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 12, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 14, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 19, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 19, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 27, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2019 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 14, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jan 29, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 28, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 27, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 27, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 5, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| May 20, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 16, 2018 | NWAP | NEW APPLICATION ENTERED | — |